SynopsisA liquid nitrogen trap is a baffle that includes an internal reservoir for liquid nitrogen. They are designed to be routinely filled from a bulk liquid nitrogen tank. A device to condense gas molecules onto a metallic surface exposed to vacuum by cooling the s.....
SynopsisAlirocumab is a human monoclonal antibody. It works by helping the liver reduce levels of "bad" cholesterol (low-density lipoprotein, or LDL) circulating in your blood.Alirocumab is used in adults with heart disease to lower the risk of heart attack, stroke, a.....
SynopsisAlemtuzumab is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. In CLL, it has been used as both a first line and second line treatment. In MS it is generally only recommended if other treatments have not worked. It is give.....
SynopsisEvolocumab(trade name Repatha) is a monoclonal antibody medication designed for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that .....
SynopsisMatuzumab (formerly known as the experimental drug, EMD 72000) is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR (epithelial growth factor receptor), frequently associated with the growth of blood vessels in malignanc.....
SynopsisAfutuzumab, more commonly known as obinutuzumab is a humanized type II monoclonal antibody against CD20 (coded for by MS4A1 for the treatment of Chronic lymphocytic leukemia, CLL. It may have more direct antibody-dependent cell-mediated cytotoxicity and possib.....
SynopsisIt is a dosage form administered subcutaneously for the treatment of relapsing forms of multiple sclerosis in adults. The global Ofatumumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % d.....
SynopsisSecukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis. The global Secukinumab market was valued at US$ mi.....
SynopsisTMB-PS (TMBZ-PS, TetraMethyl BisPhenol S, Bis-(2,6dimethyl-4-hydroxyphenyl)-sulfone) is a chromogenic reagent for the detection of hydrogen peroxide e.g. in the enzymatic analysis of body fluids. The global TMB-PS market was valued at US$ million in 2023.....
SynopsisD-Luciferin, also known as beetle luciferin or (D-(-)-2-(6'-hydroxy-2'-benzothiazolyl)-thiazoline-4-carboxylic acid), has a formula weight of 318.41 and is a synthetically made substrate which can be catalyzed by firefly luciferase. D-Luciferin is lyophilized.....
